CRIS Current Research Information System

TADOLINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.773
AS - Asia 4.475
EU - Europa 2.789
SA - Sud America 312
AF - Africa 282
Continente sconosciuto - Info sul continente non disponibili 269
OC - Oceania 14
Totale 12.914
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.664
SG - Singapore 1.267
CN - Cina 1.124
VN - Vietnam 954
GB - Regno Unito 805
IT - Italia 425
SE - Svezia 408
DE - Germania 326
HK - Hong Kong 292
BR - Brasile 222
KR - Corea 198
FR - Francia 191
IN - India 186
RU - Federazione Russa 173
BD - Bangladesh 149
IE - Irlanda 93
JP - Giappone 91
ZA - Sudafrica 81
NL - Olanda 77
FI - Finlandia 73
CI - Costa d'Avorio 68
CA - Canada 58
SC - Seychelles 56
EE - Estonia 43
AR - Argentina 41
UA - Ucraina 40
ID - Indonesia 36
TG - Togo 32
PH - Filippine 28
MX - Messico 24
TW - Taiwan 24
CH - Svizzera 21
AT - Austria 20
JO - Giordania 19
TH - Thailandia 17
BE - Belgio 16
IQ - Iraq 15
PK - Pakistan 15
BG - Bulgaria 14
PL - Polonia 14
TR - Turchia 14
AU - Australia 13
EC - Ecuador 13
GR - Grecia 11
CO - Colombia 8
MA - Marocco 8
NG - Nigeria 8
CL - Cile 7
ES - Italia 7
MY - Malesia 7
ET - Etiopia 6
JM - Giamaica 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
DZ - Algeria 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
VE - Venezuela 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
AL - Albania 3
AZ - Azerbaigian 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
LS - Lesotho 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
GT - Guatemala 2
KZ - Kazakistan 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
Totale 12.631
Salva come PNG Salva come JPEG
Città #
Singapore 871
Southend 745
Ashburn 529
Fairfield 379
Hefei 377
Santa Clara 327
Hong Kong 282
Ho Chi Minh City 252
San Jose 248
Hanoi 212
Chandler 208
Wilmington 187
Houston 185
Seoul 185
Woodbridge 178
Seattle 173
Cambridge 147
Beijing 136
Princeton 128
Ann Arbor 117
Council Bluffs 115
Dallas 105
Boardman 100
Dublin 93
Dong Ket 88
Lauterbourg 81
New York 80
Tokyo 80
Bologna 76
Abidjan 68
Los Angeles 64
Milan 64
Buffalo 58
Nanjing 56
Helsinki 55
Frankfurt am Main 50
Westminster 46
Bengaluru 40
Padova 40
Dearborn 35
San Diego 33
Lomé 32
Saint Petersburg 30
Haiphong 29
Johannesburg 29
Berlin 28
Rome 28
Da Nang 26
Nuremberg 26
Redondo Beach 26
São Paulo 25
The Dalles 23
Jakarta 22
Toronto 21
Atlanta 19
Bern 19
Amman 18
Des Moines 16
Nanchang 16
Phoenix 16
Rimini 16
Brussels 15
Falls Church 15
Amsterdam 14
Chicago 14
Hebei 14
Shanghai 14
Sofia 14
Tongling 14
Changsha 13
Falkenstein 13
Guangzhou 13
Hải Dương 13
Jinan 13
San Francisco 13
Shenyang 13
Yubileyny 13
Bremen 12
Bangkok 11
Jacksonville 11
Lappeenranta 11
Moscow 11
Munich 11
Naples 11
Orem 11
Redwood City 11
Tianjin 11
Washington 11
Zhengzhou 11
Biên Hòa 10
Denver 10
London 10
Turin 10
Can Tho 9
Chennai 9
Montreal 9
Warsaw 9
Chengdu 8
Jiaxing 8
Mexico City 8
Totale 8.209
Salva come PNG Salva come JPEG
Nome #
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 440
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 254
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 253
Vaccination in post-tuberculosis lung disease management: A review of the evidence 210
First evaluation of QuantiFERON-TB gold plus performance in contact screening 199
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 191
IGRA test for TB in COVID-19: role of corticosteroids 188
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF 186
TB consilia and quality of tuberculosis management 184
The International Journal of Tuberculosis and Lung Disease (IJTLD) 183
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 180
Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings 179
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review 177
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 177
World Tuberculosis Day 2023 theme “Yes! We Can End TB!” 176
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 173
Seventeen cases of Mycobacterium marinum infection in Italy: A multicenter retrospective study 172
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 171
Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay 171
Tuberculosis elimination: Theory and practice in Europe 169
Update of drug-resistant tuberculosis treatment guidelines: A turning point 168
A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European respiratory society-World Health Organization tuberculosis consilium 168
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 165
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 164
Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases 162
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 161
Combined use of delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis: A systematic review 161
Overview of fever of unknown origin in adult and paediatric patients 161
Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs 160
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 159
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 157
Systematic Tuberculosis Screening in Asylum Seekers in Italy 156
Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019 155
Clinical standards for drug-susceptible pulmonary TB 155
Clinical standards for the management of adverse effects during treatment for TB 155
Clinical standards for the dosing and management of TB drugs 155
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: Early experiences and challenges 155
The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011 153
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis 151
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort 150
Compassionate and optimum use of new tuberculosis drugs 150
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study 148
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 146
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 146
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians 145
First independent evaluation of QuantiFERON-TB Plus performance 145
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine 144
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis 142
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study 141
Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: A systematic review 139
Quantiferon-TB performs better in children, including infants, than in adults with active tuberculosis: a multicentre study 139
Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017–2019 138
Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey 137
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 136
Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis 134
Recommendations for treating children with drug-resistant tuberculosis 134
Recommendations for the diagnosis of pediatric tuberculosis 132
ERS/WHO Tuberculosis Consilium: Reporting of the initial 10 cases 131
New and repurposed drugs for pediatric multidrug-resistant tuberculosis practice-based recommendations 129
Paediatric tuberculosis in Europe: Lessons from Denmark and inclusive strategies to consider 128
WHO strategies for the programmatic management of drug-resistant tuberculosis 126
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline 126
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort 126
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 126
Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium 125
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 125
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use 123
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 118
Faster for less: The new "shorter" regimen for multidrug-resistant tuberculosis 117
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts 112
Introduction of bedaquiline for the treatment of multi-drug resistant tuberculosis at country level: implementation plan 108
On tuberculosis and COVID-19 co-infection 104
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report 101
National population-based tuberculosis prevalence survey in Ghana, 2013 99
A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: The ERS-WHO TB consilium 96
TB mortality in low-incidence countries: can we reduce it further? 92
National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned 89
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 82
Gauging the impact of the COVID-19 pandemic on tuberculosis services: A global study 80
Reducing tuberculosis transmission: A consensus document from the World Health Organization Regional Office for Europe 78
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond 74
We cannot eliminate TB without TB drugs: a wake-up call from Italy 71
COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom 69
High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey 69
TB outpatient care in a high-income, low-incidence country 65
Ten common myths about drug-susceptible TB 64
Consolidated guidance on tuberculosis data generation and use. Module 3. National tuberculosis prevalence surveys. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO 64
null 64
National TB prevalence surveys in the COVID-19 era 59
null 57
Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature 51
Post-tuberculosis lung disease: a guide for clinicians 30
Clinical Images: A thorn injury, a sea‐borne culprit, and a tenosynovitis dilemma 19
Impact of the COVID-19 pandemic on tuberculosis services in a rural area of Senegal 17
Totale 12.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.076 0 72 79 116 109 54 28 79 30 101 210 198
2022/20231.111 84 134 66 137 104 100 42 63 234 19 77 51
2023/2024470 30 62 37 50 53 108 14 21 31 36 16 12
2024/20252.082 36 272 122 120 407 119 131 60 23 109 143 540
2025/20265.020 474 589 557 375 498 275 406 136 712 328 364 306
2026/2027315 182 133 0 0 0 0 0 0 0 0 0 0
Totale 12.914